These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2942236)

  • 1. DNA lesions in human neoplastic cells and cytotoxicity of 5-fluoropyrimidines.
    Lönn U; Lönn S
    Cancer Res; 1986 Aug; 46(8):3866-70. PubMed ID: 2942236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma.
    Lönn U; Lönn S
    Cancer Res; 1988 Aug; 48(15):4153-7. PubMed ID: 2968838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole.
    Lönn U; Lönn S; Nylen U; Winblad G
    Cancer Res; 1989 Mar; 49(5):1085-9. PubMed ID: 2521812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma.
    Lönn U; Lönn S
    Cancer Res; 1984 Aug; 44(8):3414-8. PubMed ID: 6430549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased growth inhibition and DNA lesions in human colon adenocarcinoma cells treated with methotrexate or 5-fluorodeoxyuridine followed by calmodulin inhibitors.
    Lönn U; Lönn S
    Cancer Res; 1988 Jun; 48(12):3319-23. PubMed ID: 2453268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced repair of X-ray-induced DNA lesions in cells without functioning DNA polymerase alpha.
    Lönn U; Lönn S
    Radiat Res; 1985 Apr; 102(1):71-5. PubMed ID: 3920725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of methotrexate on incorporation and excision of 5-fluorouracil residues in human breast carcinoma DNA.
    Herrick DJ; Major PP; Kufe DW
    Cancer Res; 1982 Dec; 42(12):5015-7. PubMed ID: 7139606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of 5-bromo-2'-deoxyuridine incorporation into DNA of human glioma cell lines and modulation with fluoropyrimidines.
    Mancini WR; Stetson PL; Lawrence TS; Wagner JG; Greenberg HS; Ensminger WD
    Cancer Res; 1991 Feb; 51(3):870-4. PubMed ID: 1824826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-Fluorouracil incorporation in DNA of human breast carcinoma cells.
    Major PP; Egan E; Herrick D; Kufe DW
    Cancer Res; 1982 Aug; 42(8):3005-9. PubMed ID: 6212116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines.
    Damon LE; Christensen S; Rochlitz C; Cadman EC
    Anticancer Res; 1989; 9(6):1761-7. PubMed ID: 2534035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
    Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
    Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of dacarbazine damage of human neoplastic cell DNA by aphidicolin.
    Lönn U; Lohn S
    Cancer Res; 1987 Jan; 47(1):26-30. PubMed ID: 3098406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
    Keyomarsi K; Moran RG
    Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tezacitabine enhances the DNA-directed effects of fluoropyrimidines in human colon cancer cells and tumor xenografts.
    Taverna P; Rendahl K; Jekic-McMullen D; Shao Y; Aardalen K; Salangsang F; Doyle L; Moler E; Hibner B
    Biochem Pharmacol; 2007 Jan; 73(1):44-55. PubMed ID: 17046720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive formation of DNA lesions during treatment with anti-metabolites without incorporation of the drugs into DNA.
    Lönn U; Lönn S
    Mutat Res; 1988; 200(1-2):243-7. PubMed ID: 2969077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of RNA- and DNA-directed actions of 5-fluoropyrimidines in mouse T-lymphoma (S-49) cells.
    Maybaum J; Ullman B; Mandel HG; Day JL; Sadee W
    Cancer Res; 1980 Nov; 40(11):4209-15. PubMed ID: 6451283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of heparin on the cytotoxicity and uptake of anti-neoplastic drugs in cultured Burkitt lymphoma cells.
    Wheeler RH; Bull FE; Ruddon RW
    Cancer Res; 1974 Dec; 34(12):3215-9. PubMed ID: 4429950
    [No Abstract]   [Full Text] [Related]  

  • 18. The mechanism of dNTP-unbalanced cell death induced by 5-fluorouracil and its derivatives.
    Yoshioka A; Tanaka S; Hiraoka O; Koyama Y; Hirota Y; Wataya Y
    Nucleic Acids Symp Ser; 1985; (16):245-8. PubMed ID: 2935787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
    Kufe DW; Major PP; Munroe D; Egan M; Herrick D
    Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cell lethality with incorporation of 5-fluorouracil and 5-fluorouridine into nuclear RNA in human colon carcinoma cells in culture.
    Glazer RI; Lloyd LS
    Mol Pharmacol; 1982 Mar; 21(2):468-73. PubMed ID: 7099147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.